FDA monthly preview: Key November decisions to watch

• by Mouj Hijazi

• October 29, 2026

Antibiotic precedes auto-brewery relapse

A patient developed severe endogenous alcohol intoxication 5 days after starting treatment following approximately 2 years without symptoms.

• by Andrea Surnit

• October 8, 2026

• 3 min

Endometrial cancer drug cuts progression or death risk 41%

FDA grants Priority Review following improved survival versus chemotherapy in phase 3 trial.

• by Mouj Hijazi

• October 27, 2026

• 3 min

4 societies redefine women's heart care

New multisociety guidance identifies menstrual irregularities as potential early markers of cardiovascular risk, extending prevention efforts into adolescence.

• by Teraya Smith

• October 27, 2026

• 3 min